Committee (IACUC) in the local interpretation and application of the law. is responsible for establishing guidelines and policies regulating animal use. reviewing protocols with surgical components. anesthesia/analgesia selection, and post-operative care and analgesia.
AYou will receive treatment with OPDIVO in a hospital or clinic, under the supervision of an experienced doctor. OPDIVO will be given to you as an infusion (a drip) into a vein (intravenously) over a period of 60 minutes, every 2 weeks.
However, there is hope. The Opdivo approval is actually full of promise. This drug (and many others that are currently in drug company pipelines, including a rival named Keytruda (pembrolizumab)) is in a brand new class of therapeutics called immunotherapies or immuno-oncology drugs.